Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2021 1
2023 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Systemic immune mediators reflect tumour-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast cancer.
Lopes AD, Galdino NAL, Figueiredo AB, Brianese RC, Morais KLP, De Brot M, Osório CABT, Teixeira-Carvalho A, Calsavara VF, Evangelista GFB, Alves NS, Makdissi FB, Sanches SM, Cordeiro de Lima VC, Carraro DM, Gollob KJ. Lopes AD, et al. Among authors: evangelista gfb. Immunology. 2023 Jun;169(2):229-241. doi: 10.1111/imm.13627. Epub 2023 Feb 20. Immunology. 2023. PMID: 36703241 Free article.
Systemic cytokines, chemokines and growth factors reveal specific and shared immunological characteristics in infectious cardiomyopathies.
Neves EGA, Koh CC, Padilha da Silva JL, Passos LSA, Villani FNA, Dos Santos JSC, Menezes CAS, Silva VR, Tormin JPAS, Evangelista GFB, Carvalho AT, Rocha MODC, Nascimento B, Gollob KJ, Nunes MDCP, Dutra WO. Neves EGA, et al. Among authors: evangelista gfb. Cytokine. 2021 Dec;148:155711. doi: 10.1016/j.cyto.2021.155711. Epub 2021 Sep 27. Cytokine. 2021. PMID: 34592495 Free PMC article.
Immune mechanisms and predictive biomarkers related to neoadjuvant immunotherapy response in stage III melanoma.
Figueiredo AB, Barros E Silva MJ, Evangelista GFB, Galdino NAL, Kuil LM, Santos IP, Morais KLP, Cavalcanti CM, Moredo LF, Duprat-Neto JP, Gollob KJ. Figueiredo AB, et al. Among authors: evangelista gfb. Heliyon. 2024 Jun 11;10(12):e32624. doi: 10.1016/j.heliyon.2024.e32624. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 38975149 Free PMC article.